ArticleFrontiers in allergy2026

Tezepelumab attenuates exertional symptom burden in severe asthma: insights from a real-world cohort.

Slagjana Stoshikj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.